Aldeyra Therapeutics, Inc.
ALDX
$1.83
$0.4128.87%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 9.60M | 9.19M | 10.31M | 11.69M | 11.89M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 35.27M | 45.18M | 53.31M | 61.15M | 60.12M |
| Operating Income | -35.27M | -45.18M | -53.31M | -61.15M | -60.12M |
| Income Before Tax | -33.85M | -43.19M | -50.62M | -57.70M | -55.85M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -33.85 | -43.19 | -50.62 | -57.70 | -55.85 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -33.85M | -43.19M | -50.62M | -57.70M | -55.85M |
| EBIT | -35.27M | -45.18M | -53.31M | -61.15M | -60.12M |
| EBITDA | -35.01M | -44.92M | -53.06M | -60.90M | -59.87M |
| EPS Basic | -0.56 | -0.72 | -0.85 | -0.97 | -0.94 |
| Normalized Basic EPS | -0.35 | -0.45 | -0.53 | -0.61 | -0.59 |
| EPS Diluted | -0.56 | -0.72 | -0.85 | -0.97 | -0.94 |
| Normalized Diluted EPS | -0.35 | -0.45 | -0.53 | -0.61 | -0.59 |
| Average Basic Shares Outstanding | 240.22M | 239.64M | 239.04M | 238.41M | 237.94M |
| Average Diluted Shares Outstanding | 240.22M | 239.64M | 239.04M | 238.41M | 237.94M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |